期刊文献+

HIV假病毒用于p24抗原检测试剂研制的研究 被引量:1

Research on HIV Pseudovirion as Positive Control for p24 Antigen Detecting Kit
原文传递
导出
摘要 为了解决在研制新型HIV检测试剂盒时遇到的p24蛋白阳性对照物保存不便、阳性对照物稳定性不高以及蛋白结构和聚集形式与天然HIV病毒的p24存在差异等问题,通过将改造的HIV-1骨架质粒pNL43 EGFP R-E-和包膜蛋白质粒pGX-C共转染293T细胞后分离细胞培养液,获得具有单轮感染活性的HIV-1假病毒。通过对此假病毒颗粒的天然衣壳蛋白p24和市售HIV检测试剂盒中的p24蛋白阳性对照物的阳性反应有效性和保存稳定性的检测,证明了HIV-1假病毒p24蛋白具有更易保存、更稳定、更接近天然病毒p24蛋白的优点,适宜作为HIV检测试剂盒阳性对照物。 A new kind of p24 antigen positive control was developed to provide a better solution to the problems encountered in developing a novel HIV detecting kit, such as (a) inconveniency in storing p24 positive control, (b) difficulty in maintaining p24 antigen activity, (c) differences in protein structure and aggregation mode between recombinant p24 antigen and natural p24 antigen. Modified HIV-1 skeleton plasmid pNL43 EGFP R-E- and envelope protein plasmid pGX-C were co-transfccted into 293T cell, and then culture fluid containing single-round HIV pseudovirions were collected. This kind of HIV pseudovirions possess natural core shell protein p24, which could be used as the positive control for detection of HIV p24 antigen. Through comparison of activity and stability between pseudovirion p24 antigen and positive control in common detecting kit, it was proved that pseudovirion p24 is more convenient to store, more stable and more similar to natural p24 protein structure and aggregation mode than common recombinant p24 protein.
出处 《中国生物工程杂志》 CAS CSCD 北大核心 2010年第8期13-16,共4页 China Biotechnology
基金 国家大学生创新实验计划(081000514) 北京市科委重大项目(D0906003000091)资助项目
关键词 假病毒 HIV-1 P24 ELISA Pseudovirion HIV-1 p24 ELISA
  • 相关文献

参考文献4

  • 1Mascola J R, Louder M K, Winter C, et al. Human immunodeficiency virus type 1 neutralization measured by flow cytometric quantitation of single-round infection of primary human T cells. Virol, 2002, 76 (10) : 4810-4821.
  • 2仇超,彭虹,黄相刚,任莉,潘翔,邵一鸣,徐建青.携带绿色荧光蛋白基因的单轮感染活性HIV假病毒的建立及其活性检测[J].中华微生物学和免疫学杂志,2006,26(5):394-398. 被引量:14
  • 3Weber B, Gurtler L, Thorstensson R, et al. Multicenter evaluation of a new automated forth-generation human immunodeficiency virus screening assay with a sensitive antigen detection module and high specificity. J Clin Microbiol, 2002, 40:1938-1946.
  • 4Xu Sihong, Song Aidong, Li Xiuhua, et al. Studies on national reference of HIV-1 P24 antigen. Virologica Sinica, 2006 ( 2 ) : 102-105.

二级参考文献11

  • 1Dong M,Zhang PF,Grieder F,et al.Induction of primary virus-cross-reactive human immunodeficiency virus type 1-neutralizing antibodies in small animals by using an alphavirus-derived in vivo expression system.Proc Natl Acad Sci USA,2003,100(6):3345-3350.
  • 2Jordan A,Bisgrove D,Verdin E.HIV reproducibly establishes a latent infection after acute infection ofT cells in vitro.EMBO J,2003,22(8):1868-1877.
  • 3Zhang H,Zhou Y,Alcock C,et al.Novel single-cell-level phenotypic assay for residual drug susceptibility and reduced replication capacity of drug-resistant human immunodeficiency virus type 1.J Virol,2004,78(4):1718-1729.
  • 4Eckatein DA,Sherman MP,Penn ML,et al.HIV-1 Vpr enhances viral burden by facilitating infection of tissue macrophages but not nondividing CD4+ T cells.J Exp Med,2001,194(10):1407-1419.
  • 5He J,Choe S,Walker R,et al.Human immunodeficiency virus type 1 viral protein R(Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity.J Virol,1995,69:6705-6711.
  • 6Deng HK,Liu R,Ellmeier W,et al.Identification of a major co-receptor for primary isolates of HIV-1.Nature,1996,381:661-666.
  • 7Mascola JR,Louder MK,Winter C,et al.Human immunodeficiency virus type 1 neutralization measured by flow cytometric quantitation of singleround infection of primary human T cells.J Virol,2002,76(10):4810-4821.
  • 8Gabuzda DH,Lawrence K,Langhoff E,et al.Role of vif in replication of human immunodeficiency virus type 1 in CD4+ T lymphocytes.J Virol,1992,66(11):6489-6495.
  • 9He J,Landau NR.Use of a novel human immunodeficiency virus type 1 reporter virus expressing human placental alkaline phosphatase to detect an alternative viral receptor.J Virol,1995,69(7):4587-4592.
  • 10Chang LJ,Urlacher V,Iwakuma T,et al.Efficacy and safety analyses of a recombinant human immunodeficiency virus type 1 derived vector system.Gene Ther,1999,6(5):715-728.

共引文献13

同被引文献10

  • 1Raymond S,Delobel P,Mavigner M,et al.Development andperformance of a new recombinant virus phenotypic entry assayto determine HIV-1 coreceptor usage. Journal of Clinical Virology . 2010
  • 2Hosoya N,Su Z,Wilkin T,et al.Assessing human immuno-deficiency virus type 1 tropism:comparison of assay using rep-lication-competent virus versus plasma-derived pseudotyped vi-rions. Journal of Clinical Microbiology . 2009
  • 3Fauci AS.25 years of HIV. Nature . 2008
  • 4Mascola J R,Louder M K,Winter C,et al.Human immunodeficiency virus type1neutralization measured by flow cytometric quantitation of single-round infection of primary human Tcells. Journal of Virology . 2002
  • 5Briggs JA,Wilk T,Fuller SD.Do lipid rafts mediate virus assembly and pseudotyping?. Journal of General Virology . 2003
  • 6David Avram Sanders.No false start for novel pseudotyped vectors. Current Opinion in Biotechnology . 2002
  • 7JM Whitcomb,W Huang,S Fransen,K Limoli,J Toma,T Wrin,C Chappey,LD Kiss,EE Paxinos,CJ Petropoulos.Development and characterization of a novel single-cycle recombinant-virus assay to determine human immunodeficiency virus type 1 coreceptor tropism. Antimicrobial Agents and Chemotherapy . 2007
  • 8Heyndrickx L,Vermoesen T,Vereecken K,Kurth J,Coppens S,Aerts L,Ohagen A,van Herrewege Y,Lewi P,Vanham G.Antiviral compounds show enhanced activity in HIV-1 single cycle pseudovirus assays as compared to classical PBMC assays. Journal of Virological Methods . 2008
  • 9张玉松,王大燕,徐红,舒跃龙.假病毒的最新应用研究进展[J].医学研究杂志,2008,37(6):116-118. 被引量:6
  • 10种辉辉,许四宏,王佑春.评价HIV-1抗病毒药物的重组假病毒法的建立及其初步应用[J].药物分析杂志,2008,28(6):924-927. 被引量:8

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部